Pulmonology / Original Article
Polymyxin B-hemoperfusion in patients with acute exacerbation of idiopathic pulmonary fibrosis: a single-center prospective pilot study
Min Jee Kim, Jiyoul Yang, Jin Woo Song
Korean J Intern Med. 2025;40(3):458-467. Published online April 30, 2025
Background/Aims: Patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) typically have a poor prognosis; however, no effective treatment is available. In recent years, several retrospective studies have suggested the clinical benefits of direct hemoperfusion with a polymyxin B–..
|